ArticleGenes & diseases2026

Targeting Wnt/β-catenin activation in combination with temozolomide leads to glioblastoma inhibition and long-term survival in mice.

Xiaowei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.